Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
515 A phase 1 study of myeloid modulating agent MTL-CEBPA in combination with pembrolizumab in adult patients with advanced solid tumours
Compose a Response to This Article
Other responses
No responses have been published for this article.